The World Health Organisation (WHO) has approved a COVID-19 vaccine made by Sinovac Biotech for emergency use listing.
It's the second Chinese-produced shot to get its endorsement, a WHO statement said on Tuesday.
WHO emergency listing is a signal to national regulators on a product's safety and efficacy.
It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which currently faces major supply problems.
In a statement, the independent panel of experts said it recommended Sinovac's vaccine for adults over 18, with a second dose 2-4 weeks later.
There was no upper age limit as data suggested it is likely to have a protective effect in older people.
At least 31 killed after crane falls on train in Thailand
US expected to unveil post-war Gaza leadership, sources say
Russia detains top doctors at Siberian hospital after nine babies die
Japan PM readies snap election, February 8 ballot eyed
South Korea prosecutor seeks death penalty for ex-president Yoon over martial law
